Dermatology

Latest News

FDA Approves Delgocitinib, First Treatment for Adults with Moderate to Severe Chronic Hand Eczema / image credit  ©Waldenmarus/Shutterstock.com
FDA Approves Delgocitinib, First Treatment for Adults With Moderate to Severe Chronic Hand Eczema

July 24th 2025

The nonsteroidal topical pan-JAK inhibitor provides a potent treatment option for adults with CHE who have not responded to corticosteroids or cannot tolerate them.

Atopic Dermatitis Flare Frequency May Predict Future Disease Severity, According to New Findings / image credit Courtesy of Bispebjerg Hospital
Atopic Dermatitis Flare Frequency May Predict Future Disease Severity, According to New Findings

July 21st 2025

Lebrikizumab Maintains Skin Clearance Through 3 Years in AD Patients: Daily Dose / image credit: ©New Africa/AdobeStock
Lebrikizumab Maintains Skin Clearance Through 3 Years in AD Patients: Daily Dose

July 21st 2025

Dupilumab Sustains Long-Term Reduction of S. aureus in People with AD: Daily Dose / image credit: ©New Africa/AdobeStock
Dupilumab Sustains Long-Term Reduction of S. aureus in People with AD: Daily Dose

July 16th 2025

Lebrikizumab Found Safe, Effective in Patients With Skin of Color With AD: Daily Dose / image credit: ©New Africa/AdobeStock
Lebrikizumab Found Safe, Effective in Patients With Skin of Color With AD: Daily Dose

July 15th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.